Activist 13D/13G Filings - Casdin Capital LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2024-11-14
4:08 pm
Sale		13GCentury Therapeutics Inc.
IPSC		Casdin Capital LLC3,212,316
3.800%		-1,978,190decrease
(-38.11%)		View
2024-11-08
4:33 pm
Purchase		13GNEUROGENE INC
NGNE		Casdin Capital LLC1,024,616
6.900%		1,024,616increase
(New Position)		View
2024-09-26
09:27 am
Purchase		13GCODEXIS INC.
CDXS		Casdin Capital LLC8,100,000
9.900%		8,100,000increase
(New Position)		View
2024-08-14
8:54 pm
Purchase		13DSTANDARD BIOTOOLS INC.
LAB		Casdin Capital LLC73,766,074
19.770%		3,364,737increase
(+4.78%)		View
2024-06-03
5:20 pm
Sale		13DSTANDARD BIOTOOLS INC.
LAB		Casdin Capital LLC70,401,337
18.910%		-5,936,401decrease
(-7.78%)		View
2024-05-22
4:54 pm
Purchase		13DSTANDARD BIOTOOLS INC.
LAB		Casdin Capital LLC76,337,738
20.370%		1,802,072increase
(+2.42%)		View
2024-04-18
4:36 pm
Purchase		13GCentury Therapeutics Inc.
IPSC		Casdin Capital LLC5,190,506
6.080%		1,984,126increase
(+61.88%)		View
2024-04-08
9:03 pm
Sale		13DCentury Therapeutics Inc.
IPSC		Casdin Capital LLC3,206,380
4.950%		-16,560decrease
(-0.51%)		View
2024-03-20
5:25 pm
Purchase		13DSTANDARD BIOTOOLS INC.
LAB		Casdin Capital LLC74,535,666
19.250%		9,238,070increase
(+14.15%)		View
2024-02-14
4:26 pm
Sale		13GMAXCYTE INC.
MXCT		Casdin Capital LLC0
0.000%		-9,220,000decrease
(Position Closed)		View
2024-02-14
4:20 pm
Purchase		13GRelay Therapeutics Inc.
RLAY		Casdin Capital LLC7,387,943
5.990%		1,089,369increase
(+17.30%)		View
2024-01-09
5:13 pm
Purchase		13DSTANDARD BIOTOOLS INC.
LAB		Casdin Capital LLC65,297,596
19.710%		27,715,250increase
(+73.75%)		View
2023-11-14
6:35 pm
Sale		13DEQRx Inc.
EQRX		Casdin Capital LLC0
0.000%		-56,297,042decrease
(Position Closed)		View
2023-10-24
4:29 pm
Purchase		13DBIOLIFE SOLUTIONS INC
BLFS		Casdin Capital LLC8,707,165
19.500%		1,267,058increase
(+17.03%)		View
2023-10-02
4:14 pm
Purchase		13GRelay Therapeutics Inc.
RLAY		Casdin Capital LLC6,298,574
5.160%		6,298,574increase
(New Position)		View
2023-05-08
4:15 pm
Sale		13DABSCI CORP
ABSI		Casdin Capital LLC4,448,260
4.800%		-1,085,000decrease
(-19.61%)		View
2023-03-20
4:22 pm
Sale		13DABSCI CORP
ABSI		Casdin Capital LLC5,533,260
6.000%		-940,000decrease
(-14.52%)		View
2023-02-13
9:36 pm
Sale		13GDERMTECH INC
DMTKQ		Casdin Capital LLC0
0.000%		-1,745,000decrease
(Position Closed)		View
2023-02-13
9:34 pm
Sale		13GTango Therapeutics Inc.
TNGX		Casdin Capital LLC0
0.000%		-5,487,910decrease
(Position Closed)		View
2023-02-13
9:34 pm
Sale		13GINVITAE CORP COM
NVTAQ		Casdin Capital LLC9,038,388
3.720%		-3,165,281decrease
(-25.94%)		View
Goto 0, 1, 2, Next